Qiagen (QGEN) Competitors $45.61 -0.45 (-0.98%) As of 10:40 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFDA EventsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock QGEN vs. A, DHR, TMO, ONC, INSM, BNTX, TEVA, SMMT, GMAB, and VTRSShould you be buying Qiagen stock or one of its competitors? The main competitors of Qiagen include Agilent Technologies (A), Danaher (DHR), Thermo Fisher Scientific (TMO), BeOne Medicines (ONC), Insmed (INSM), BioNTech (BNTX), Teva Pharmaceutical Industries (TEVA), Summit Therapeutics (SMMT), Genmab A/S (GMAB), and Viatris (VTRS). These companies are all part of the "medical" sector. Qiagen vs. Its Competitors Agilent Technologies Danaher Thermo Fisher Scientific BeOne Medicines Insmed BioNTech Teva Pharmaceutical Industries Summit Therapeutics Genmab A/S Viatris Qiagen (NYSE:QGEN) and Agilent Technologies (NYSE:A) are both large-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, profitability, earnings, risk, media sentiment, valuation, dividends and analyst recommendations. Is QGEN or A a better dividend stock? Qiagen pays an annual dividend of $0.25 per share and has a dividend yield of 0.5%. Agilent Technologies pays an annual dividend of $0.99 per share and has a dividend yield of 0.8%. Qiagen pays out 14.8% of its earnings in the form of a dividend. Agilent Technologies pays out 23.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Agilent Technologies has raised its dividend for 9 consecutive years. Agilent Technologies is clearly the better dividend stock, given its higher yield and longer track record of dividend growth. Which has preferable earnings and valuation, QGEN or A? Agilent Technologies has higher revenue and earnings than Qiagen. Qiagen is trading at a lower price-to-earnings ratio than Agilent Technologies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioQiagen$1.98B5.13$83.59M$1.6926.99Agilent Technologies$6.51B5.43$1.29B$4.2629.25 Does the media favor QGEN or A? In the previous week, Agilent Technologies had 13 more articles in the media than Qiagen. MarketBeat recorded 27 mentions for Agilent Technologies and 14 mentions for Qiagen. Agilent Technologies' average media sentiment score of 1.38 beat Qiagen's score of 1.00 indicating that Agilent Technologies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Qiagen 6 Very Positive mention(s) 2 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Agilent Technologies 22 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Which has more risk and volatility, QGEN or A? Qiagen has a beta of 0.64, meaning that its stock price is 36% less volatile than the S&P 500. Comparatively, Agilent Technologies has a beta of 1.24, meaning that its stock price is 24% more volatile than the S&P 500. Do analysts recommend QGEN or A? Qiagen presently has a consensus price target of $49.69, suggesting a potential upside of 8.94%. Agilent Technologies has a consensus price target of $139.25, suggesting a potential upside of 11.77%. Given Agilent Technologies' stronger consensus rating and higher possible upside, analysts plainly believe Agilent Technologies is more favorable than Qiagen.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Qiagen 0 Sell rating(s) 8 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.27Agilent Technologies 0 Sell rating(s) 6 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.50 Do institutionals and insiders believe in QGEN or A? 70.0% of Qiagen shares are held by institutional investors. 9.0% of Qiagen shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Is QGEN or A more profitable? Qiagen has a net margin of 18.30% compared to Agilent Technologies' net margin of 17.97%. Agilent Technologies' return on equity of 25.51% beat Qiagen's return on equity.Company Net Margins Return on Equity Return on Assets Qiagen18.30% 14.77% 8.87% Agilent Technologies 17.97%25.51%12.94% SummaryAgilent Technologies beats Qiagen on 15 of the 19 factors compared between the two stocks. Get Qiagen News Delivered to You Automatically Sign up to receive the latest news and ratings for QGEN and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding QGEN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart QGEN vs. The Competition Export to ExcelMetricQiagenMED IndustryMedical SectorNYSE ExchangeMarket Cap$10.14B$3.18B$5.82B$21.58BDividend Yield0.54%2.32%5.69%3.53%P/E Ratio26.9421.5074.8629.83Price / Sales5.13297.34467.6653.52Price / Cash14.3545.3337.0824.51Price / Book2.849.6812.094.60Net Income$83.59M-$53.32M$3.29B$999.91M7 Day Performance-4.05%0.87%1.42%0.97%1 Month Performance-6.88%9.65%7.70%4.96%1 Year Performance2.95%13.23%62.04%16.15% Qiagen Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)QGENQiagen4.468 of 5 stars$45.61-1.0%$49.69+8.9%+3.3%$10.14B$1.98B26.945,765Positive NewsAAgilent Technologies4.6425 of 5 stars$125.63+0.5%$139.25+10.8%-8.5%$35.69B$6.79B29.4917,900Positive NewsDHRDanaher4.9888 of 5 stars$206.09+0.4%$247.61+20.1%-28.2%$147.57B$23.88B43.8563,000News CoveragePositive NewsDividend AnnouncementTMOThermo Fisher Scientific4.963 of 5 stars$493.05+0.7%$593.00+20.3%-20.6%$186.18B$42.88B28.52125,000Trending NewsAnalyst UpgradeInsider TradeAnalyst RevisionONCBeOne Medicines1.7218 of 5 stars$306.05+2.7%$330.89+8.1%N/A$33.54B$4.56B-176.9111,000Insider TradeINSMInsmed3.3624 of 5 stars$136.10+0.8%$132.57-2.6%+100.4%$28.77B$363.71M-23.841,271Positive NewsBNTXBioNTech2.5408 of 5 stars$100.00-1.9%$135.80+35.8%+5.1%$24.04B$2.88B-62.506,772TEVATeva Pharmaceutical Industries2.5304 of 5 stars$18.41+2.0%$24.71+34.3%+10.7%$21.11B$16.54B-115.0436,830SMMTSummit Therapeutics3.118 of 5 stars$23.70-2.9%$33.31+40.5%-18.1%$17.61B$700K-23.47110Insider TradeGMABGenmab A/S3.9818 of 5 stars$24.87-1.0%$37.60+51.2%+6.2%$15.96B$3.26B12.502,682News CoveragePositive NewsGap UpVTRSViatris1.5982 of 5 stars$10.55+1.3%$10.40-1.4%-10.3%$12.30B$14.12B-3.6432,000Positive News Related Companies and Tools Related Companies A Alternatives DHR Alternatives TMO Alternatives ONC Alternatives INSM Alternatives BNTX Alternatives TEVA Alternatives SMMT Alternatives GMAB Alternatives VTRS Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:QGEN) was last updated on 9/12/2025 by MarketBeat.com Staff From Our PartnersNVDA: The cracks are beginning to showThe media hasn't caught up to the story yet, but when they do, this stock could leave Nvidia in the dust. I...InvestorPlace | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAlert: Prepare for Trump's Dollar OverhaulPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredUrgent: $3,452.50 a Month in Passive "AI Equity Checks"The U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredCollege grad makes $64,000 a monthA Wall Street legend just helped train our own proprietary AI system in the stock market (a project that took ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Qiagen N.V. Please log in to your account or sign up in order to add this asset to your watchlist. Share Qiagen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free QGEN Stock Alerts